ALX Oncology Holdings Inc.ALX Oncology Holdings Inc.ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc.

No trades
See on Supercharts

Price target

10.400.000.00%
The 5 analysts offering 1 year price forecasts for ALXO have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings to ALXO in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ALXO EPS for the last quarter is −0.58 USD despite the estimation of −0.78 USD. In the next quarter EPS is expected to reach −0.67 USD. Track more of ALX Oncology Holdings Inc. financials and stay on top of what is up with the company.
In the next quarter ALX Oncology Holdings Inc. revenue is expected to reach 0.00 USD. Check out ALX Oncology Holdings Inc. revenue and earnings and make informed decisions.
According to analysts, ALXO price target is 10.40 USD with a max estimate of 25.00 USD and a min estimate of 3.00 USD. Check if this forecast comes true in a year, meanwhile watch ALX Oncology Holdings Inc. stock price chart and keep track of the current situation with ALXO news and stock market news.
We've gathered opinions of 7 analysts rating ALXO stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.